Back to LPCN

Eversept Partners, LP → LPCN

Eversept Partners, LP LPCN Position History

Lipocine Inc. • Healthcare

Quarters held
3
Latest value
$646K
Q3 2026
Peak value
$2.4M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$2.4M
Q2 2026$755K
Q3 2026$646K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$646K293.8K——
Q2 2026$755K295.0K——
Q1 2026$2.4M295.0K——

Other funds holding LPCN

Other Eversept Partners, LP positions

UTHR

UNITED THERAPEUTICS CORP DEL

$176M
UTHR

UNITED THERAPEUTICS CORP DEL

$156.7M
UTHR

UNITED THERAPEUTICS CORP DEL

$155.9M
VERA

VERA THERAPEUTICS INC

$155.6M
EHC

ENCOMPASS HEALTH CORP

$131.5M
GLAXF

GSK PLC

$131.4M
ENSG

ENSIGN GROUP INC

$124.9M
UTHR

UNITED THERAPEUTICS CORP DEL

$123.1M